MedicarePartD.guide

A non-government resource built from CMS public data

emtricitabine-tenofovir on HealthSpring Assurance Rx (S5617-216)

generic Truvada

Covered.

Tier 4 (non-preferred drug). Quantity limit of 30 per 30 days.

$257.54
Patient pays / month, after deductible
$681.89
Patient pays / month, before the $615.00 deductible
$772.61
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200/300 mg Tablet, Film Coated at a preferred retail pharmacy, from the plan's negotiated price of $830.76 for a month. Other covered strengths are listed below.

All 4 covered strengths and forms
FormTierPatient pays / monthLimits
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200/300 mg Tablet, Film Coated4$257.5430 per 30 days
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100/150 mg Tablet, Film Coated4$260.4930 per 30 days
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133/200 mg Tablet, Film Coated5$213.2730 per 30 days
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167/250 mg Tablet, Film Coated4$264.4830 per 30 days

Other HIV drugs on this plan

Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5617-216